Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Carbohydr Polym ; 216: 332-342, 2019 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-31047074

RESUMEN

Chitosan has received a lot of attention as a carrier for small interfering RNA (siRNA), due to its capacity for complexation and intracellular release of these molecules. However, one of its limitations is its insolubility at neutral pH and the tendency towards aggregation of its nanoparticles in isotonic ionic strength. In this study, a series of amphipathic chitosans were synthesized by varying the degree of acetylation (DA) from ˜2 to ˜30 mol% and the degree of substitution (DS) from 5 to 25%. by tertiary amino groups (DEAE) The results showed that the adjustment of these parameters decreases the interparticle interactions mediated by hydrogen bonding to obtain nanoparticles with improved colloidal stability. siRNA-containing nanoparticles of 100 to 150 nm with low polydispersities (0.15-0.2) and slightly positive zeta potentials (˜+ 5 mV) were resistant to aggregation at pH 7.4 and ionic strength of 150 mM. This resistance to aggregation is provided by changes on the nanoparticle surface and highlights the importance of more organized self-assembly in providing colloidal stability at physiological conditions. Additionally, the PEGylation of the most promising vectors conferred favorable physicochemical properties to nanoparticles. The chitosans and their nanoparticles exhibited low toxicity and an efficient cell uptake, as probed by confocal microscopy of rhodamine labeled vectors. The results provide a new approach to overcome the limited stability of chitosan nanoparticles at physiological conditions and show the potential of these amphipathic chitosans as siRNA carriers.


Asunto(s)
Quitosano/análogos & derivados , Portadores de Fármacos/química , Nanopartículas/química , ARN Interferente Pequeño/administración & dosificación , Tensoactivos/química , Anhídridos Acéticos/química , Acetilación , Animales , Quitosano/síntesis química , Quitosano/metabolismo , Quitosano/toxicidad , Dietilaminas/química , Portadores de Fármacos/síntesis química , Portadores de Fármacos/metabolismo , Portadores de Fármacos/toxicidad , Fluorescencia , Colorantes Fluorescentes/química , Concentración de Iones de Hidrógeno , Ratones , Nanopartículas/metabolismo , Nanopartículas/toxicidad , Tamaño de la Partícula , Polietilenglicoles/síntesis química , Polietilenglicoles/química , Polietilenglicoles/metabolismo , Polietilenglicoles/toxicidad , Células RAW 264.7 , ARN Interferente Pequeño/química , Rodaminas/química , Tensoactivos/síntesis química , Tensoactivos/metabolismo , Tensoactivos/toxicidad
2.
Cell Biol Int ; 31(3): 235-45, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17123842

RESUMEN

Mongolian gerbils (Meriones unguiculatus) were grouped into two experimental groups: GEx.01 suffered orchiectomy and after 30 days received doses of testosterone cipionate (T), while GEx.02 received weekly and alternated doses of the anti-androgens cyproterone acetate and flutamide for 30 days, and the animals were then euthanized. Structural evaluation reveals a more intense reduction in epithelial height in GEx.02. Smooth muscle cells (SMC) presented a star-shaped aspect after 30 days of hormonal ablation and basal membrane was shown to be more intensely grooved in GEx.01. In both groups, after hormonal replacement, recovery in epithelial height could be noted and the SMC presented its phenotypes, but an increase in RER was seen, characterizing a modulation from its contractile to secreting phenotype. In conclusion, the prostate presented involution capacity after androgen ablation and the ability to reorganize after hormonal replacement, but events resulting from orchiectomy and subsequent T replacement were shown to be more aggressive to the prostate.


Asunto(s)
Antagonistas de Andrógenos/administración & dosificación , Orquiectomía , Próstata/patología , Hiperplasia Prostática/patología , Testosterona/administración & dosificación , Fosfatasa Ácida , Animales , Ciproterona , Modelos Animales de Enfermedad , Retículo Endoplásmico Rugoso/ultraestructura , Endotelio/ultraestructura , Flutamida , Gerbillinae , Inmunohistoquímica , Masculino , Microscopía Electrónica de Transmisión , Orquiectomía/métodos , Tamaño de los Órganos/efectos de los fármacos , Próstata/efectos de los fármacos , Próstata/crecimiento & desarrollo , Próstata/metabolismo , Hiperplasia Prostática/inducido químicamente , Hiperplasia Prostática/metabolismo , Proteínas Tirosina Fosfatasas/metabolismo , Receptores Androgénicos/efectos de los fármacos , Receptores Androgénicos/metabolismo , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...